We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+5.28%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$5.14B
AUM Growth
+$467M
(+10%)
Cap. Flow
+$273M
Cap. Flow
% of AUM
5.31%
Top 10 Holdings %
Top 10 Hldgs %
11.46%
Holding
1,074
New
159
Increased
412
Reduced
333
Closed
136
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$28.6M |
| 2 |
AGN
Allergan plc
AGN
|
+$26.5M |
| 3 |
Toro Company
TTC
|
+$22.4M |
| 4 |
PepsiCo
PEP
|
+$20.4M |
| 5 |
Lockheed Martin
LMT
|
+$17.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intuit
INTU
|
+$26.1M |
| 2 |
Wells Fargo
WFC
|
+$19.4M |
| 3 |
Centene
CNC
|
+$17.3M |
| 4 |
Eli Lilly
LLY
|
+$15.8M |
| 5 |
Kroger
KR
|
+$14.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.58% |
| 2 | Financials | 18.08% |
| 3 | Industrials | 12.96% |
| 4 | Healthcare | 11.05% |
| 5 | Consumer Discretionary | 11.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Camden Property Trust
CPT
$11.3B
| $11.4M | 0.22% |
124,257
-44,788
| -26% | -$4.03M |
|
152
Boston Properties
BXP
$11B
| $11M | 0.21% |
89,834
-22,017
| -20% | -$2.67M |
|
153
Cencora
COR
$60.3B
| $10.7M | 0.21% |
129,461
+87,141
| +206% | +$7.39M |
|
154
Insperity
NSP
$1.85B
| $10.6M | 0.21% |
241,950
-28,520
| -11% | -$1.13M |
|
155
Norfolk Southern
NSC
$78.8B
| $10.6M | 0.21% |
80,121
+17,081
| +27% | +$2.08M |
|
|
WBC
156
DELISTED
WABCO HOLDINGS INC.
WBC
| $10.5M | 0.2% |
70,874
+45,784
| +182% | +$6.35M |
|
|
VRNT
157
DELISTED
Verint Systems
VRNT
| $10.4M | 0.2% |
489,798
+324,725
| +197% | +$6.55M |
|
158
Costco
COST
$415B
| $10.3M | 0.2% |
62,994
+22,105
| +54% | +$3.47M |
|
159
Ciena
CIEN
$55.3B
| $10.2M | 0.2% |
463,088
+313,268
| +209% | +$7.5M |
|
160
TJX Companies
TJX
$170B
| $10.1M | 0.2% |
275,268
-263,152
| -49% | -$9.37M |
|
161
Ameriprise Financial
AMP
$46.8B
| $10.1M | 0.2% |
68,318
+25,705
| +60% | +$3.59M |
|
162
TD Synnex
SNX
$19.4B
| $10M | 0.2% |
158,814
+10,260
| +7% | +$605K |
|
163
Werner Enterprises
WERN
$2.54B
| $9.99M | 0.19% |
273,235
+217,545
| +391% | +$6.91M |
|
164
Travelers Companies
TRV
$80.8B
| $9.99M | 0.19% |
81,506
-13,034
| -14% | -$1.63M |
|
165
Gilead Sciences
GILD
$161B
| $9.96M | 0.19% |
122,998
-189,656
| -61% | -$14.5M |
|
|
ARCH
166
DELISTED
Arch Resources, Inc.
ARCH
| $9.81M | 0.19% |
+136,809
| New | +$10.2M |
|
|
LNW
167
DELISTED
Light & Wonder
LNW
| $9.74M | 0.19% |
212,410
-27,980
| -12% | -$976K |
|
168
Argan
AGX
$7.98B
| $9.74M | 0.19% |
144,807
+18,330
| +14% | +$1.15M |
|
|
SFLY
169
DELISTED
Shutterfly, Inc.
SFLY
| $9.73M | 0.19% |
200,808
+54,109
| +37% | +$2.55M |
|
170
Synchrony
SYF
$23.7B
| $9.7M | 0.19% |
312,240
-280,479
| -47% | -$8.39M |
|
171
Stryker
SYK
$127B
| $9.49M | 0.18% |
66,841
+37,721
| +130% | +$5.41M |
|
172
MarketAxess Holdings
MKTX
$4.15B
| $9.46M | 0.18% |
51,270
+10,260
| +25% | +$1.96M |
|
173
Silicon Laboratories
SLAB
$7.15B
| $9.45M | 0.18% |
118,326
-9,732
| -8% | -$724K |
|
174
AutoZone
AZO
$48.3B
| $9.44M | 0.18% |
15,865
-11,575
| -42% | -$6.17M |
|
175
Tapestry
TPR
$28.8B
| $9.42M | 0.18% |
+233,833
| New | +$10.3M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q3 2017 Portfolio in Review
As of Q3 2017, Jacobs Levy Equity Management held 1,074 positions worth $5.14B, up 10% from $4.68B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jacobs Levy Equity Management deployed $273M of net new capital in Q3 2017, opening 159 new positions and adding to 412 existing holdings. Its largest new stake was Allergan plc: 114,141 shares worth $23.4M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Intuit, an estimated $26.1M trimmed.
- Jacobs Levy Equity Management's largest Q3 2017 buy was Allergan plc: 114,141 shares worth $23.4M.
- Jacobs Levy Equity Management added most to Philip Morris in Q3 2017, an estimated $28.6M increase.
- Jacobs Levy Equity Management's biggest Q3 2017 reduction was Intuit, cutting an estimated $26.1M.
- Jacobs Levy Equity Management fully exited BWX Technologies in Q3 2017, selling an estimated $13.7M.
- Jacobs Levy Equity Management's ten largest holdings make up 11% of its $5.14B portfolio in Q3 2017.
- Jacobs Levy Equity Management opened 159 new positions and closed 136 in Q3 2017.
- Jacobs Levy Equity Management's portfolio value rose 10% quarter-over-quarter to $5.14B.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2017, filed 14 Nov 2017.